Home Other Building Blocks [Sar-9, Met(O2)-11]-Substance P

[Sar-9, Met(O2)-11]-Substance P

CAS No.:
110880-55-2
Catalog Number:
AG00838V
Molecular Formula:
C24H39N5O6S
Molecular Weight:
525.6614
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1mg
98%
1 week
United States
$190
- +
5mg
98%
1 week
United States
$540
- +
10mg
98%
1 week
United States
$923
- +
25mg
98%
1 week
United States
$1890
- +
Product Description
Catalog Number:
AG00838V
Chemical Name:
[Sar-9, Met(O2)-11]-Substance P
CAS Number:
110880-55-2
Molecular Formula:
C24H39N5O6S
Molecular Weight:
525.6614
MDL Number:
MFCD00076787
IUPAC Name:
(2S)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2S)-2-amino-5-(diaminomethylideneamino)pentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-N-[(2S)-5-amino-1-[[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-amino-4-methylsulfonyl-1-oxobutan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-2-oxoethyl]-methylamino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1,5-dioxopentan-2-yl]pentanediamide
InChI:
InChI=1S/C64H100N18O15S/c1-38(2)34-46(57(89)74-42(54(69)86)28-33-98(4,96)97)73-53(85)37-80(3)62(94)48(36-40-18-9-6-10-19-40)79-58(90)47(35-39-16-7-5-8-17-39)78-56(88)43(24-26-51(67)83)75-55(87)44(25-27-52(68)84)76-59(91)50-23-15-32-82(50)63(95)45(21-11-12-29-65)77-60(92)49-22-14-31-81(49)61(93)41(66)20-13-30-72-64(70)71/h5-10,16-19,38,41-50H,11-15,20-37,65-66H2,1-4H3,(H2,67,83)(H2,68,84)(H2,69,86)(H,73,85)(H,74,89)(H,75,87)(H,76,91)(H,77,92)(H,78,88)(H,79,90)(H4,70,71,72)/t41-,42-,43-,44-,45-,46-,47-,48-,49-,50-/m0/s1
InChI Key:
OUPXSLGGCPUZJJ-SARDKLJWSA-N
SMILES:
CNC(C(=O)N(CC(=O)NC(C(=O)NC(C(=O)N)CCS(=O)(=O)C)CC(C)C)C)Cc1ccccc1
UNII:
8V0QAFPRXV
Properties
Complexity:
2880  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
10  
Defined Bond Stereocenter Count:
0
Exact Mass:
1392.734g/mol
Formal Charge:
0
Heavy Atom Count:
98  
Hydrogen Bond Acceptor Count:
18  
Hydrogen Bond Donor Count:
14  
Isotope Atom Count:
0
Molecular Weight:
1393.675g/mol
Monoisotopic Mass:
1392.734g/mol
Rotatable Bond Count:
42  
Topological Polar Surface Area:
553A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-3.4  
Literature
Title Journal
Synthesis and structure-activity relationship studies in serotonin 5-HT(1A) receptor agonists based on fused pyrrolidone scaffolds. European journal of medicinal chemistry 20130501
Evidence for regulatory diversity and auto-regulation at the TAC1 locus in sensory neurones. Journal of neuroinflammation 20110101
Discovery of {1-[4-(2-{hexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl}-1H-benzimidazol-1-yl)piperidin-1-yl]cyclooctyl}methanol, systemically potent novel non-peptide agonist of nociceptin/orphanin FQ receptor as analgesic for the treatment of neuropathic pain: design, synthesis, and structure-activity relationships. Bioorganic & medicinal chemistry 20101101
Substance P sensitizes P2X3 in nociceptive trigeminal neurons. Journal of dental research 20101001
The neurokinin-1 receptor modulates the methamphetamine-induced striatal apoptosis and nitric oxide formation in mice. Journal of neurochemistry 20091101
Neurokinin receptor modulation of respiratory activity in the rabbit. The European journal of neuroscience 20080601
Expression and coupling of neurokinin receptor subtypes to inositol phosphate and calcium signaling pathways in human airway smooth muscle cells. American journal of physiology. Lung cellular and molecular physiology 20080301
Pharmacological characterization of T-2328, 2-fluoro-4'-methoxy-3'-[[[(2S,3S)-2-phenyl-3-piperidinyl]amino]methyl]-[1,1'-biphenyl]-4-carbonitrile dihydrochloride, as a brain-penetrating antagonist of tachykinin NK1 receptor. Journal of pharmacological sciences 20080101
Effect of melatonin on the vasopressin secretion as influenced by tachykinin NK-1 receptor agonist and antagonist: in vivo and in vitro studies. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20071201
Substance P excites globus pallidus neurons in vivo. The European journal of neuroscience 20071001
Role for NK(1) and NK(2) receptors in the motor activity in mouse colon. European journal of pharmacology 20070910
Neurokinin-1 receptor activation in Botzinger complex evokes bradypnoea. The Journal of physiology 20060915
Characteristics of substance P transport across the blood-brain barrier. Pharmaceutical research 20060601
Upregulation of tachykinin NK-1 and NK-3 receptor binding sites in the spinal cord of spontaneously hypertensive rat: impact on the autonomic control of blood pressure. British journal of pharmacology 20060501
Ava[L-Pro9,N-MeLeu10] substance P(7-11) (GR 73632) and Sar9, Met(O2)11 increase distention-induced peristalsis through activation of neurokinin-1 receptors on smooth muscle and interstitial cells of cajal. The Journal of pharmacology and experimental therapeutics 20060401
Neurokinin-1 receptor in peripheral nerve terminals mediates thermal hyperalgesia. Biochemical and biophysical research communications 20060106
Activation of central neurokinin-1 receptors induces reinstatement of cocaine-seeking behavior. Neuroscience letters 20051216
The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation. British journal of pharmacology 20050701
Elimination of rat spinal neurons expressing neurokinin 1 receptors reduces bladder overactivity and spinal c-fos expression induced by bladder irritation. American journal of physiology. Renal physiology 20050301
A model of organotypic rat spinal slice culture and biolistic transfection to elucidate factors that drive the preprotachykinin-A promoter. Brain research. Brain research reviews 20041001
Neurokinin-1 and -3 receptor blockade inhibits slow excitatory synaptic transmission in myenteric neurons and reveals slow inhibitory input. Neuroscience 20040101
Substance P modulates localized calcium transients and membrane current responses in murine colonic myocytes. British journal of pharmacology 20030401
Evidence for a GABA(B) receptor component in the spinal action of Substance P (SP) on arterial blood pressure in the awake rat. British journal of pharmacology 20020801
Chemical coding and electrophysiology of enteric neurons expressing neurofilament 145 in guinea pig gastrointestinal tract. The Journal of comparative neurology 20020114
Permissive role of neurokinin NK(3) receptors in NK(1) receptor-mediated activation of the locus coeruleus revealed by SR 142801. Synapse (New York, N.Y.) 20020101
Assessing the emetic potential of PDE4 inhibitors in rats. British journal of pharmacology 20020101
Peripheral inflammation reduces the response of spinal dorsal horn neurons to an NK3 receptor agonist. Neuroscience letters 20010727
Priming effects of substance P on calcium changes evoked by interleukin-8 in human neutrophils. Journal of leukocyte biology 20010601
Effect of the long-acting tachykinin NK(1) receptor antagonist MEN 11467 on tracheal mucus secretion in allergic ferrets. British journal of pharmacology 20010101
Treatment of gastric ulcers and diarrhea with the Amazonian herbal medicine sangre de grado. American journal of physiology. Gastrointestinal and liver physiology 20000701
NK1-receptor activation prevents hydrocarbon-induced lung injury in mice. The American journal of physiology 19990201
Properties